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Summary objectives To summarise age- and intensity-stratiﬁed associations between human hookworm
infection and anaemia and to quantify the impact of treatment with the benzimidazoles, albendazole and
mebendazole, on haemoglobin and anaemia in non-pregnant populations.
methods Electronic databases (MEDLINE, EMBASE, PubMed) were searched for relevant studies
published between 1980 and 2009, regardless of language, and researchers contacted about potential
data. Haemoglobin concentration (Hb) was compared between uninfected individuals and individuals
harbouring hookworm infections of different intensities, expressed as standardised mean differences
(SMD) and 95% conﬁdence intervals (CI). Meta-analysis of randomised control trials (RCTs) investi-
gated the impact of treatment on Hb and anaemia.
results Twenty-three cross-sectional studies, six pre- and post-intervention studies and 14 trials were
included. Among cross-sectional studies, moderate- and heavy-intensity hookworm infections were
associated with lower Hb in school-aged children, while all levels of infection intensity were associated
with lower Hb in adults. Among RCTs using albendazole, impact of treatment corresponded to a
1.89 g⁄l increase (95%CI: 0.13–3.63) in mean Hb while mebendazole had no impact. There was a
positive impact of 2.37 g⁄l (95%CI: 1.33–3.50) on mean Hb when albendazole was co-administered
with praziquantel, but no apparent additional beneﬁt of treatment with benzimidazoles combined with
iron supplementation. The mean impact of treatment with benzimidazoles alone on moderate anaemia
was small (relative risk (RR) 0.87) with a larger effect when combined with praziquantel (RR 0.61).
conclusions Anaemia is most strongly associated with moderate and heavy hookworm infection. The
impact of anthelmintic treatment is greatest when albendazole is co-administered with praziquantel.
keywords hookworm, Necator americanus, Ancylostoma duodenale, anaemia, haemoglobin, anthel-
mintic treatment
Introduction
Hookworms (Necator americanus and Ancylostoma duo-
denale) reside in the small intestine of infected individuals
where they attach themselves to the villi and feed on host
blood. Among individuals with inadequate iron intake and
high physiological demands, this blood loss can result in
anaemia. The link between hookworm and anaemia was
ﬁrst established in the nineteenth century (Perroncito
1880), and during the subsequent 130 years, there have
been numerous reviews of the extensive literature in this
area (Layrisse & Roche 1964; Miller 1979; Schad &
Banwell 1984; Crompton & Stephenson 1990; Crompton
& Whitehead 1993; Stoltzfus et al. 1997; Brooker et al.
2004; Hotez et al. 2004). There is a direct relationship
between the number of hookworms an individual harbours
(the intensity of infection) and the amount of intestinal
blood lost attributable to hookworm (Gilles & Williams
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The clinical consequences of this loss will depend on the
host’s underlying iron status as well as the presence of
other causes of anaemia (Fleming 2000). Studies indicate
that there is some worm burden threshold above which
clinically signiﬁcant anaemia is likely to occur, with the
precise threshold dependent on the host’s iron status
(Lwambo et al. 1992). As well as inﬂuencing morbidity,
worm burden is a key determinant of transmission
dynamics and hence the rate of reinfection following
anthelmintic treatment (Anderson & May 1985). Intensity
of infection may also inﬂuence the efﬁcacy of treatment
(Bennett & Guyatt 2000). It follows therefore that as the
intensity of hookworm infection varies considerably
between populations, the risk of anaemia attributable to
hookworm and the impact of treatment will differ among
populations.
In 2007, a systematic review of randomised controlled
trials (RCTs) investigating the impact of anthelmintic
treatment reported an increase in haemoglobin concentra-
tion (Hb) of 1.71 g⁄l after treatment (Gulani et al. 2007).
But this review did not distinguish between different
helminth species or account for intensity of infection,
which may have underestimated the true treatment effect
(Awasthi & Bundy 2007); the effect of treatment is likely
to be greatest where hookworm is most prevalent and
intense. Recent work has quantiﬁed hookworm-related
anaemia among pregnant women (Brooker et al. 2008).
The present work aims to quantify the impact of
hookworm infection and anthelmintic treatment using
benzimidazoles, albendazole and mebendazole, among
non-pregnant populations in hookworm-endemic areas.
Speciﬁcally, we review available data from cross-sectional
studies that investigated the relationship between intensity
of hookworm infection and Hb. We also summarise
available data from RCTs and pre- and post-intervention
observational studies that compared the effects of benz-
imidazole treatment, either alone or in combination with
the anti-schistosomal drug praziquantel, on Hb and anae-
mia levels. Finally, based on the value of combining
deworming with micronutrient supplementation in chil-
dren, we evaluate the impact of treatment in combination
with iron supplementation (Hall 2007).This work con-
tributes to the current reassessment of the global burden of
disease (Murray et al. 2007).
Methods
Identiﬁcation of cross-sectional studies
The bibliographic databases of MEDLINE (http://medline.
cos.com/), EMBASE (http://www.embase.com/) and
PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) were
searched for relevant studies in 2006 and again in April
2009. For analysis of the association between intensity of
hookworm infection and anaemia, the following Medical
Subject Headings (MSHs) were used to identify relevant
studies published between 1980 and 2009: hookworm,
Necator americanus, Ancylostoma duodenale, an(a)emia,
h(a)emoglobin and h(a)ematocrit. Cross-sectional studies
published prior to 1980 were reviewed, but those pre-
senting relevant statistics were found to use different
diagnostic test and intensity thresholds, making compari-
sons with later studies difﬁcult (Beaver 1951; Carr 1926;
Chernin 1954). Returned abstracts were reviewed and full
texts retrieved if they contained relevant information.
References from articles and key reviews were screened for
additional studies. Finally, leading researchers in the area
and authors of key papers were contacted to ask about
unpublished or unindexed data, and this yielded a number
of additional studies. Non-English language journals were
included in the search, and relevant articles were assessed
against the inclusion⁄exclusion criteria by native speakers.
No distinction could be made between the two different
hookworm species, Necator americanus and Ancylostoma
duodenale, as none of the studies used diagnostic methods
able to differentiate species.
The primary outcome for analysis was haemoglobin
concentration (Hb) in non-pregnant populations, and our
hypothesis was that haemoglobin concentration is associ-
ated with the intensity of hookworm infection as assessed
by quantitative egg counts, expressed as eggs per gram
(epg)⁄faeces. Abstracted data included the mean Hb,
corresponding standard deviation (SD) and number of
individuals infected for each category of hookworm
infection intensity and were entered into an Excel database.
When data were not reported in the preferred format,
authors were contacted to request relevant data summaries.
Data were stratiﬁed by age group (0–4, 5–19 and 20+
years) and category of infection intensity (light, 0–1999
epg; moderate, 2000–3999 epg; heavy, 4000+ epg)) (WHO
2002).
Identiﬁcation of treatment studies
Treatment studies were identiﬁed using the MSHs dewor-
ming, anti-helmint(h)ic, anthelmint(h)ic, anthelminth,
mebendazole, praziquantel, pyrantel, piperazine, nitazox-
anide, levamisole, albendazole, bephenium and niclosa-
mide. Only trials that randomised individuals to treatment
with a benzimidazole (BMZ) anthelmintic drug and a
control group, either placebo or standard of care, and
conducted in hookworm-endemic areas were included.
Only studies from 1980 onwards were identiﬁed because
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and albendazole in 1980 and use of these benzimidazoles in
public health interventions post-dates 1980 (Horton 2003).
Two additional groups of studies were included: (i) RCTs
of BMZ combined with praziquantel (PQZ) treatment
for schistosomiasis and (ii) RCTs of BMZ treatment
combined with iron supplementation. In addition to RCTs,
observational studies of the impact of intervention were
reviewed. Studies that did not quantify the baseline
prevalence of hookworm infection, were conducted in
pregnant populations, or used an anthelmintic other than
albendazole (ABZ) or mebendazole (MBZ) were excluded
as these drugs are not widely used in large-scale treatment
programmes. Trials were assessed by recommended criteria
as shown in Table S2, but quality was not summarised
using a score and incomplete reporting was not followed
up with authors. These decisions were based on reported
unreliability of scales in assessing quality and on the
possibility of introducing bias (Higgins & Green 2009).
Primary outcomes were change in mean Hb and preva-
lenceofanaemia,basedonthehypothesisthatHbwilldiffer
between intervention and control group in response to
anthelmintic treatment. Abstracted data included the base-
lineprevalenceofhookworminfectionandanaemia,andthe
post-treatment relative risk of hookworm infection, preva-
lence of anaemia, mean Hb and change in Hb in each group,
with corresponding SDs. For studies that did not report the
prevalence of anaemia, an approximation was made on
the basis of the reported mean and standard deviation Hb.
The proportion of individuals with Hb below the age-
speciﬁc thresholds for mild, moderate and severe anaemia
wascalculatedassuminganormalHbdistribution(Sharman
2000; WHO 2008). For studies that evaluated treatment
effectatmultipletimepoints,onlydatafromthelongesttime
interval were included in the analysis.
Data analysis
The difference in Hb among different intensity categories
was expressed as pool estimates of standardised mean
difference (SMD) based on a meta-analysis using a DerSi-
monian and Laird random effects model. All P values are
from two-tailed tests of signiﬁcance where alpha is equal to
0.05.
The impact of treatment was assessed using two
approaches. First, for RCTs and observational studies, the
impact of treatment on the prevalence of anaemia was
expressed as a relative risk (RR) and mean impact
summarised. Second, for RCTs, a DerSimonian and Laird
random effects meta-analysis was conducted to provide
pooled estimates of the effect of treatment on Hb, and a
metaregression was used to identify sources of variation
between studies. The analysis was stratiﬁed by co-admin-
istration of PQZ in the intervention arm. This design was
justiﬁed by the lack of an equivalent intervention in the
control arm of these trials and their incomparability to
those speciﬁcally evaluating the impact of BMZ treatment.
SMDs were transformed into g⁄l using a mean of the SDs
of included studies. Linear regression analysis was used to
summarise relative risk of mild and moderate anaemia and
identify potential determinants of anaemia impact. Study
characteristics that were investigated in the modelling
process included: age category, WHO region, intervention,
baseline prevalence and intensity of hookworm infection,
mean Hb at baseline, dosage schedule and follow-up
period. Sensitivity analysis identiﬁed the Stephenson et al.
(1993) study as responsible for signiﬁcant variation in the
results, and this study was therefore excluded from further
analysis on the basis that participants were restricted to
those with heavier infections.
Heterogeneity between studies was assessed by an I
2 test,
with values greater than 50% representing signiﬁcant
heterogeneity, and a sensitivity analysis and preliminary
metaregression identiﬁed potential sources of variation.
Results were displayed as forest plots. Publication bias was
investigated by the construction of funnel plots and by the
Egger and Begg statistical tests. Analysis was performed
using the ‘metan’ and related functions in STATA version
10 (College Station, TX).
Results
Associations between hookworm intensity and
haemoglobin
The search identiﬁed 423 citations, from which 117 unique
and potentially relevant articles were retrieved. Of these,
48 were determined to be eligible and 14 had suitable
cross-sectional data, including 11 surveys among school-
aged children and seven among non-pregnant adults
1.I n
addition, unpublished data were available for nine studies.
Eighteen studies were conducted in Africa, one in South
Asia, four in Southeast Asia and one in Latin America.
Survey characteristics are described in Table S1. For all
populations, prevalence estimates for hookworm infection
ranged from 0.3 to 96%, with 12.5% of the surveys having
a mean intensity of infection >1000 epg and eight studies
having no individuals with infection intensity >2000 epg.
Prevalence of anaemia (110 g⁄l or 120 g⁄l threshold)
ranged between 4.5 and 90%.
1Only two studies among pre-school children (Stoltzfus et al.
2000; Brooker et al. 1999) were identiﬁed and therefore no further
analysis among this age group was undertaken.
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aged children uninfected and those harbouring different
levels of infection intensity. There was no evidence for a
difference in Hb between uninfected and lightly infected
children (SMD )0.04, 95%Conﬁdence interval [CI]:
)0.11 to 0.03) (Figure 1a), but there was evidence for a
Study ID
(a)
(b)
Study ID
[3] Stephenson, 1985
[4] Stephenson, 1981
[3] Stephenson, 1985
[4] Stephenson, 1981
[5] Srinivasan, 1987
[6] PCD Ghana, 1998
[7] PCD Tanzania, 1999
[6] PCD Ghana, 1998
[7] PCD Tanzania, 1999
[8] Stoltfus, 1997
[8] Stoltfus, 1997
[9] Olsen, 1998
[10] Beasley, 1999
[16] Beasley, 2000
[10] Beasley, 1999
[11] Miguel & Kremer, 1999
[11] Miguel & Kremer, 1999
[13] PCD Eritrea, 1999
[17] PCD, 2003
[18] IPT, 2005
[19] Kabatereine, 2007
[20] Koukounari, 2006
[21] Khieu, 2006
[2] Brooker, 2007
[22] Brooker, 2009
[14] SAVE, 2000
[15] SCF 2000
[15] SCF 2000
Overall (I-squared = 72.8%, P = 0.000)
NOTE: Weights are from random effects analysis
[16] Beasley, 2000
[17] PCD, 2003
[18] IPT, 2005
[19] Kabatereine, 2007
[20] Koukounari, 2006
[21] Khieu, 2006
[2] Brooker, 2007
[22] Brooker, 2009
Overall (I-squared = 57.6%, P = 0.002)
NOTE: Weights are from random effects analysis
SMD (95% Cl) % Weight
SMD (95% Cl) % Weight
1.93
2.81
3.48
7.38
5.57
6.18
4.24
6.23
6.45
0.46
4.54
3.66
6.29
6.26
7.08
6.21
7.81
2.98
3.93
6.51
7.90
7.11
1.71
8.11
11.47
9.09
8.12
1.67
3.56
7.51
6.88
4.49
9.90
3.34
7.42
1.71
100.00
–1.5 –2.5 –.5 0 .5
–1.5 –2.5 –.5 0 .5
100.00
0.14 (–0.29, 0.57)
0.00 (–0.09, 0.09)
0.07 (–0.10, 0.23)
0.21 (–0.02, 0.44)
–0.34 (–0.48, –0.20)
–0.09 (–0.23, 0.05)
–0.14 (–0.27, –0.02)
–0.28 (–1.26, 0.70)
0.19 (–0.02, 0.41)
0.18 (–0.09, 0.44)
0.07 (–0.07, 0.20)
–0.24 (–0.37, –0.10)
0.07 (–0.03, 0.17)
–0.26 (–0.39, –0.12)
0.00 (–0.06, 0.06)
–0.10 (–0.42, 0.22)
0.16 (–0.09, 0.41)
0.04 (–0.08, 0.17)
–0.04 (–0.11, –0.03)
–0.33 (–0.77, 0.11)
–0.77 (–1.26, –0.27)
0.29 (–1.10, 1.67)
–0.41 (–0.83, 0.02)
–0.90 (–1.10, –0.69)
–1.17 (–1.53, –0.81)
–0.43 (–0.85, –0.01)
0.39 (–1.01, –1.79)
–0.62 (–1.50, –0.26)
–1.30 (–1.76, –0.84)
–0.31 (–0.82, 0.20)
–0.94 (–1.68, 0.19)
–0.43 (–0.73, –0.12)
–1.02 (–1.93, –0.10)
–0.49 (–0.96, 0.02)
–0.08 (–1.31, 1.47)
–0.64 (–0.84, 0.45)
–0.13 (–0.46, 0.20)
–0.35 (–0.63, –0.07)
Figure 1 Forest plot of the difference in haemoglobin concentration (Hb) among school-aged children (a) uninfected with hookworm and
children with a light (1–1999 eggs⁄gram) hookworm infection and (b) uninfected with hookworm and children with a heavy
(4000+ eggs⁄gram) hookworm infection. Standardised mean difference less than zero indicates lower Hb levels in children harbouring
infections compared to uninfected children. The area of the shaded box represents the contribution (or weight) assigned to the estimate of
effect from each study (centre point). The diamond represents the overall pooled estimates of the effect of hookworm infection on Hb.
Study ID refer to references in Table S1.
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(SMD )0.32, 95% CI )0.46 to )0.18) or heavily (SMD
)0.64, 95% CI )0.84 to )0.45) infected children
(Figure 1b). There was signiﬁcant heterogeneity in differ-
ences between studies but that could not be explained by
any single study. However, a higher baseline prevalence
of anaemia was weakly associated with lower Hb in
lightly or moderately infected children compared to
uninfected children (P = 0.06), suggesting that children
with poor underlying iron status may be more likely to
suffer the consequences of light hookworm infection than
those with better nutritional status. There was some
evidence of non-symmetry in the funnel plot of uninfected
children compared to those with a moderate infection and
weak evidence of publication bias using the Egger’s test
but not Begg’s test.
Among adults, there was evidence for progressively
lower Hb among individuals lightly infected (SMD )0.15,
95% CI )0.29 to )0.00) (Figure 2a), moderately infected
(SMD )0.47, 95% CI )0.77 to -.17) and heavily infected
(SMD )0.93, 95% CI )1.43 to )0.44) relative to those
uninfected (Figure 2b). There was evidence of heterogene-
ity of effect that could be explained by speciﬁc studies in
each infection strata which, when excluded, altered the
SMD (in parenthesis): Brooker et al. (2007a), the only
study in Latin America (SMD )0.21, 95% CI )0.30 to
)0.11); Latham et al. (1982) among Kenya male road
workers in Kenya (SMD )0.36, 95% CI )0.53 to )0.19);
and Olsen et al. (1998) in a highly malaria endemic area
(SMD )0.71, 95% CI )1.07 to 0.34). No evidence of
publication bias was detected in any of the other age group
or intensity strata.
Impact of anthelmintic treatment
Of the 31 studies identiﬁed, 14 RCTs met the criteria for
inclusion, of which 10 evaluated the effects of either ABZ
or MBZ treatment alone (Table 1), four evaluated ABZ
treatment with PQZ (Table 2), and ﬁve evaluated
treatment in combination with iron supplementation
(Table 3). In addition, six observational studies were
included (Tables 1–3). The majority of studies were
conducted in Africa (75%), predominantly in East Africa,
used ABZ (85%), and were conducted among school-aged
children (75%) (Table 4). Of the RCTs, most studies were
individually randomised (79%) and double blind (77%),
while seven used a factorial study design to evaluate
deworming in combination with iron supplementation.
The mean follow-up period for all studies was
3.8 months. Marked variation in the prevalence of
hookworm and anaemia (using different thresholds)
existed between studies.
Across all 20 RCTs and observational studies, the mean
change in Hb was higher in the treatment arm for all
intervention packages than in the control arm: 2.3 g⁄l
higher in the BMZ group; 3.7 g⁄l higher in the BMZ and
PQZ group; 2.7 g⁄l higher in the BMZ and iron group; and
3.0 g⁄l higher in the BMZ, PQZ and iron group (Table 4).
The effect of BMZ alone on mild and moderate anaemia
was small (mean RR of 0.91 and 0.77), whereas the mean
RR of BMZ plus PQZ was 0.72 for mild anaemia and 0.58
for moderate anaemia.
Eleven RCTs reported the effect of intervention on mean
Hb with corresponding standard deviations (SD) or
allowed their estimation (three studies did not report SDs:
Awasthi et al. 2000; Stoltzfus et al. 2004; Nga et al. 2009).
There was no overall effect of BMZ (SMD 0.05, 95%CI:
)0.02 to 0.12), but looking at the drug effects separately,
treatment with ABZ corresponded to a 1.89 g⁄l increase in
mean Hb (SMD 0.15, 95% CI 0.01 to 0.29) whereas MBZ
had no apparent impact (Figure 3a). Furthermore, com-
bining ABZ and PQZ resulted in a 2.37 g⁄l increase in
mean Hb (SMD 0.23, 95% CI 0.13 to 0.34) (Figures 3b).
There was no evidence to support a beneﬁcial impact
of BMZ treatment when iron supplementation was
co-administered in both arms of the trial (SMD 0.09, 95%
CI )0.09 to 0.27) compared to neither arm (SMD 0.04,
95% CI )0.04 to 0.12).
Among RCTs, treatment with BMZ alone had little
impact on the risk of mild (RR 0.98, 95%CI: 0.89–1.06)
and moderate (RR 0.87, 95%CI, 0.59–1.15) anaemia as
determined by linear regression. When BMZ treatment was
co-administered with PQZ, the mean relative risks of mild
and moderate anaemia were 0.67 (95% CI )0.11 to 1.45)
and 0.61 (95% CI 0.58–0.64). Among studies administer-
ing BMZ alone, a higher Hb at baseline was associated
with a larger impact on moderate anaemia (P = 0.02), but
there was no evidence of a differential impact when iron
supplementation was co-administered in both arms of the
trial (P = 0.69 and P = 0.63). No determinants of impact
were identiﬁed for studies co-administering BMZ and
PQZ.
Discussion
The aetiology of tropical anaemia is complex, but the
present systematic review conﬁrms that hookworm infec-
tions of moderate or heavy intensity are associated with
lower Hb levels in both school-aged children and adults
(Layrisse & Roche 1964; Stoltzfus et al. 1997). The
mechanisms by which hookworms reduce Hb are well
established: adult worms attached to intestinal villi and pass
a stream of blood through their intestines to obtain oxygen
and nutrients. Fortunately, however, the current results
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improving Hb levels, but that the effects of treatment
appear to differ according the benzimidazole drug used
(Figure 3). Among the included RCTs, treatment using
albendazole was associated with an 1.89 g⁄l increase in Hb,
whereas mebendazole treatment afforded no apparent
beneﬁt. However, the impact of benzimidazole treatment
on Hb is enhanced by the co-implementation of
praziquantel treatment and iron supplementation: for
example, the addition of praziquantel resulted in a 2.37 g⁄l
increase.
WHO currently recommends that school-aged children
living in areas of high prevalence of soil-transmitted
helminths (hookworms, Ascaris lumbricoides and Trichu-
ris trichiura) receive mass treatment with either albenda-
zole or mebendazole (WHO, 2002). Whilst these drugs are
Study ID
Study ID
[23] Areekil, 1979
[23] Areekil, 1979
[24] Latham, 1982
[5] Srinivasari, 1987
[8] Stolzfus, 1997
[8] Stolzfus, 1997
[9] Olsen, 1998
[9] Olsen, 1998
[25] Nguyen, 2006
[25] Nguyen, 2006
[2] Brooker, 2007
[2] Brooker, 2007
Overall (I-squared = 80.4%, P = 0.000)
NOTE: Weights are from random effects analysis
–1.5 –2.5
(b)
–.5 0 .5
Overall (I-squared = 90.8%, P = 0.000)
NOTE: Weights are from random effects analysis
–1.5 –2.5 –.5 0 .5
SMD (95% Cl)
15.26
13.04
13.21
13.10
14.32
18.74
12.33
100.00
23.97
22.89
7.69
23.67
21.78
100.00
% Weight
SMD (95% Cl) % Weight
–0.06 (–0.24, 0.11)
–0.06 (–0.30, 0.18)
–0.63 (–0.86, –0.40)
–0.20 (–0.44, 0.03)
–0.20 (–0.40, 0.00)
–0.19 (–0.25, –0.13)
0.30 (0.04, 0.55)
–0.15 (–0.31, –0.00)
–1.12 (–1.34, –0.91)
–0.77 (–1.07, –0.47)
–4.11 (–5.59, –2.64)
–0.66 (–0.90, –0.42)
–0.07 (–0.45, 0.31)
–0.93 (–1.43, –0.44)
(a)
Figure 2 Forest plot of the difference in haemoglobin concentration (Hb) among non-pregnant adults (a) uninfected with hookworm
and adults with a light (1–1999 eggs⁄gram) hookworm infection and (b) uninfected with hookworm and adults with a heavy
(4000+ eggs⁄gram) hookworm infection. Standardised mean difference less than zero indicates lower Hb levels in adults harbouring
infections compared to uninfected adults. The area of the shaded box represents the contribution (or weight) assigned to the estimate of
effect from each study (centre point). The diamond represents the overall pooled estimates of the effect of hookworm infection on Hb.
Study ID refer to references in Table S1.
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788 ª 2010 Blackwell Publishing LtdTable 4 Summary of 20 hookworm intervention studies investigating the impact of benzimidazole treatment (BMZ) on haemoglobin
concentration (Hb), administered alone or in combination with praziquantel (PQZ) or iron
Number of studies Mean (range)
Region Sites
Asia, South Bangladesh 1
India 1
Asia, Southeast Viet Nam 3
sub-Saharan Africa, East Kenya 4
Tanzania 5
Uganda 1
sub-Saharan Africa, Southern South Africa 1
sub-Saharan Africa, West Benin 1
Burkina Faso 1
Co ˆte d’Ivoire 1
Niger 1
Study design: Observational studies 6
Randomised controlled trials 14
Benzimidazole type Albendazole 17
Mebendazole 3
Assessed BMZ alone 11
BMZ + PQZ 9
BMZ + iron 5
BMZ + PQZ + iron 3
Age category (years) 0–4 3
5–18 15
18–70 2
Study duration (months) 20 9.4 (1.6–24)
Mean baseline hookworm prevalence (%) 20 50.7 (3.6–100)
Mean baseline hookworm intensity (epg) 14 1387(5.6–6229)
Mean relative risk of infection* 14 0.58 (0–1.2)
BMZ Alone
Comparison arm mean change in Hb 10 2.5 ()6 to 15.4)
Intervention arm mean change in Hb 10 4.0 ()4 to 14.6)
Increase in mean change in Hb 11 +2.3 ()0.8 to 9.3)
Mean relative risk of Hb<115 g⁄l 11 0.91 (0.56–1.5)
Mean relative risk of Hb<100 g⁄l 10 0.77 (0.21–1.34)
BMZ + PQZ
Comparison arm mean change in Hb 4 )1.9 ()5.8 to 5.5)
Intervention arm mean change in Hb 4 0.6 ()3.8 to 8.6)
Increase in mean change in Hb 8 +3.7 (2–8.8)
Mean relative risk of Hb<115 g⁄l 8 0.72 (0.31–0.9)
Mean relative risk of Hb<100 g⁄l 7 0.58 (0.23–0.8)
BMZ + iron
Comparison arm mean change in Hb 4 9.2 (2.4–17.8)
Intervention arm mean change in Hb 4 10.2 (2.5–17.5)
Increase in mean change in Hb 5 +2.7 ()0.3–9.2)
Mean relative risk of Hb<115 g⁄l 5 0.93 (0.51–1.2)
Mean relative risk of Hb<100 g⁄l 5 0.67 (0.1–1.6)
BMZ + PQZ + iron
Comparison arm mean change in Hb 3 1.0 ()3.9 to 9.2)
Intervention arm mean change in Hb 3 4.0 ()1.9 to 10.4)
Increase in mean change in Hb 2 +3.0 (1.2–5.9)
Mean relative risk of Hb<115 g⁄l 2 0.94 (0.9–1.0)
Mean relative risk of Hb<100 g⁄l 2 1.11 (0.9–1.3)
*The reduction in the prevalence of hookworm infection at the time of follow-up (intervention group⁄control group).
Limited to randomised controlled trials.
PQZ administered in the intervention arm only, iron in both intervention and control groups.
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ª 2010 Blackwell Publishing Ltd 789both highly efﬁcacious against A. lumbricoides, with
demonstrable gains for growth and school performance
(Taylor-Robinson et al. 2007; Bundy et al. 2009), single-
dose mebendazole treatment is less effective against
T. trichiura and hookworm (Keiser & Utzinger 2008).
Thus, the differential impact of albendazole and meben-
dazole on Hb levels can be explained in part by their
varying efﬁcacies against hookworm, although it should be
Study ID
Study ID
Albendazole
Albendazole with Praziquantel
Albendazole without Praziquantel
Stephenson 1990
Stephenson 1990
Adams 1994
Dossa 2001
Dossa 2001
Gilgen 2001
Gilgen 2001
Adams 1994
Dossa 2001
Dossa 2001
Gilgen 2001
Gilgen 2001
Taylor 2001
Taylor 2001
Friis 2003
Friis 2003
Beasley 1999
Rohner 2010
Rohner 2010
Mebendazole
Stolzfus 1998
Thi Le 2007
Thi Le 2007
Subtotal (I-squared = 0.0%, P = 0.997)
Subtotal (I-squared = 0.0%, P = 0.997)
Subtotal (I-squared = 0.0%, P = 0.434)
Subtotal (I-squared = 0.0%, P = 0.730)
Overall (I-squared = 0.0%, P = 0.885)
NOTE: Weights are from random effects analysis
–1.5 –2.5 –.5 0
1.45
1.05
1.79
2.25
2.21
9.23
8.72
25.24
64.17
5.23
5.36
74.76
100.00
2.46
3.09
3.03
12.68
11.99
34.69
4.28
3.89
16.44
16.80
11.05
6.27
6.58
65.31
100.00 0.21 (0.12, 0.29)
0.23 (0.13, 0.34)
0.22 (–0.10, 0.55)
0.30 (–0.03, 0.63)
0.31 (0.06, 0.56)
0.23 (0.02, 0.43)
0.08 (–0.12, 0.29)
0.21 (–0.12, 0.63)
0.61 (0.21, 1.01)
0.15 (0.01, 0.29)
0.15 (–0.09, 0.39)
0.12 (–0.11, 0.36)
0.14 ( –0.33, 0.62)
0.24 (–0.23, 0.71)
0.11 (–0.42, 0.64)
0.27 (–0.42, 0.95)
0.05 (–0.02, 0.12)
0.01 (–0.07, 0.10)
–0.04 (–0.34, 0.27)
–0.09 (–0.40, 0.22)
0.03 (–0.06, 0.11)
0.15 (0.01, 0.29)
0.15 (–0.09, 0.39)
0.12 (–0.11, 0.36)
0.14 (–0.33, 0.62)
0.24 (–0.23, 0.71)
0.11 (–0.42, 0.64)
0.27 (–0.42, 0.95)
NOTE: Weights are from random effects analysis
Overall (I-squared = 0.0%, P = 0.850)
–1.5 –2.5 –.5 0 .5
.5
(b)
(a)
SMD (95% Cl) % Weight
SMD (95% Cl) % Weight
Figure 3 Forest plot of the difference in the mean change in haemoglobin concentration (Hb) among individuals treated with an
anthelmintic and individuals given a placebo in interventions studies (n = 10). Standardised mean difference greater than zero indicates a
greater increase in Hb levels in the treated group (or a smaller decrease) compared to the control group. The area of the shaded box
represents the contribution (or weight) assigned to the treatment effect estimated from each study (centre point). Diamonds represent
pooled estimates among studies stratiﬁed by (a) benzimidazole type in those studies not administering praziquantel and (b) co-adminis-
tration of praziquantel in the intervention arm. The lowest diamond represents the overall pooled estimates of the effect of any treatment
on the mean change in Hb.
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mebendazole against hookworm vary among populations
(Keiser & Utzinger 2008). However, this review identiﬁed
only three published RCTs that investigated the impact of
mebendazole on Hb, making it difﬁcult to draw difﬁcult
deﬁnite conclusions about the effect of mebendazole in
different hookworm-endemic regions of the world.
In areas co-endemic with schistosomiasis, benzimidazole
is typically co-implemented with praziquantel. Previous
attempts to quantify the haematological beneﬁts of pra-
ziquantel have been hindered by the lack of RCTs
evaluating the effects of PQZ alone (Friedman et al. 2005).
Praziquantel has a direct effect against schistosomes, which
may cause anaemia through a variety of proposed mech-
anisms, including extra-corporeal blood loss, sequestration
of red blood cells, haemolysis and inﬂammation (Friedman
et al. 2005). A previous systematic review of schistosomi-
asis-related morbidity (King et al. 2005) identiﬁed ﬁve
studies evaluating the impact of praziquantel on Hb levels
in hookworm-endemic areas; but two of these trials
co-administered benzimidazole or metrifonate treatment.
Metrifonate is partially effective against hookworm infec-
tion (Kurz et al. 1986), and therefore, inclusion of studies
using metrifonate would potentially overestimate the
impact of praziquantel treatment. A large multi-centre
RCT of praziquantel and albendazole included by King
et al. (2005) found that only treatment with praziquantel
had an impact on Hb, but the estimate of impact for
albendazole was not reported (Olds et al. 1999).
One of the difﬁculties of attributing effects of hookworm
and anthelmintic treatment on anaemia, particularly
among populations exposed to malaria and with inade-
quate dietary intake, is the exclusion of other causes. The
multiple aetiologies of anaemia can confound cross-sec-
tional estimates of association and inﬂuence the observed
impact of anthelmintic treatment. Malaria (both symp-
tomatic and asymptomatic) is an important aetiological
factor for anaemia operating through several mechanisms
including increased destruction of red blood cells (RBCs)
through rupturing, phagocytosis and hypersplenism and
reduced RBC production through inﬂammation and
dyserythropiesis (Kurtzhals et al. 1999; Menendez et al.
2000; Tolentino et al. 2007). Extensive geographic overlap
of hookworm and malaria yields a high prevalence of
co-infection, which may increase in an additive manner the
risk of anaemia (Brooker et al. 2007b). A further aetio-
logical factor for anaemia is schistosomiasis, and
co-infection with schistosomes and hookworm has been
associated with enhanced anaemia risk (Ezeamama et al.
2008; Stephenson et al. 1985; Brito et al. 2006). In the
present review, cross-sectional studies did not report
adjusted intensity-stratiﬁed estimates of Hb and only 5
RCTs stratiﬁed results by nutritional status. Studies
reported conﬂicting results: some found a differential
impact based on anaemic status (Beasley et al. 1999) and
intensity of hookworm infection (Stoltzfus et al. 1998;
Adams et al. 1994), while others found no difference in
impact between these groups (Taylor et al. 2001; Friis
et al. 2003). Among children with S. mansoni infections,
Friis et al. 2003 reported a greater impact on Hb associ-
ated with malaria co-infection, suggesting that malaria
may inﬂuence the impact of schistosomiasis treatment.
A further potentially confounding factor is anthelmintic
treatment efﬁcacy. Reported estimates of the impact of
benzimidazole treatment may underestimate the true
magnitude of association because of incomplete treatment
cure and the potential reinfection that occurs during
follow-up (Bradley et al. 1993; Stoltzfus et al. 2000).
Reinfection dynamics of helminths are well described and
depend on a number of factors that vary between
populations, including transmission intensity, efﬁcacy of
treatment and treatment coverage (Anderson & Schad
1985). Studies of hookworm reinfection support the view
that prevalence and intensity of hookworm infection can
return to pre-treatment levels within 1–2 years, with
reinfection fastest in areas of high transmission and where
treatment efﬁcacy and coverage is lowest (Quinnell et al.
1993; Schad & Anderson 1985; Reynoldson et al. 1997 &
De Clerq et al. 1997). A related issue is variation in
follow-up time of included studies because a longer
follow-up will allow more opportunities for reinfection
and may therefore underestimate the impact of treatment
on haemoglobin.
Diagnostic uncertainty may introduce additional bias.
The dominant hookworm species present as well as the
haemoglobin and diagnostic methods may inﬂuence
observed impact. Few of the included studies distinguished
between the two hookworm species N. americanus and
A. duodenale because of the practical difﬁculties of
differential diagnosis. However, it is suggested that
A. duodenale causes greater blood loss than N. americanus
(Pawlowski et al. 1991), with data from Zanzibari
schoolchildren indicating that A. duodenale is associated
with an increased risk of anaemia (Albonico et al. 1998).
Finally, although Hb is routinely assessed as a measure of
iron stores, it is insensitive to signiﬁcant (20–30%)
decreases in iron stores from higher Hb levels and is not
speciﬁc to iron-deﬁciency anaemia (Zimmermann 2008).
Other indicators of iron stores might provide a more
sensitive measure of baseline nutritional status and
inﬂuence the observed impact.
In conclusion, this systematic review conﬁrms the
beneﬁts of anthelmintic treatment for improving Hb levels
of infected populations but highlights important differ-
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and the package of interventions treatment is combined
with. This ﬁnding highlights the need for continual
evaluation of the beneﬁcial effects of deworming on Hb,
with randomised evaluations providing the most robust
evidence. However, there is also a need for rigorous, long-
term evaluation of large-scale control programmes to
ensure that they are having maximal beneﬁts for the
targeted populations. This would avoid denying individu-
als the beneﬁts of treatment through randomised evalua-
tions. The results additionally emphasise the public health
beneﬁts of combing health interventions and are of
particular relevance to efforts implementing an integrated
school health package, which may include deworming,
iron supplementation, school feeding and malaria control
(Bundy et al. 2006).
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